28
Oct
2025

OMGENE LIFE SCIENCES PRIVATE LIMITED

Exhibitor at CPHI Frankfurt 2025 stand 12.1F127, API
About Us

Omgene Life Sciences Private Limited is a Research and Development (R&D) based organization, which was incorporated in March 2011 and has been operating for around 12 years in bio-pharmaceutical research. At Omgene, we are involved in niche product development research for preparation of Peptide API, semi-Synthetic API, Synthetic API molecules, biopharmaceuticals and formulation of complex generics for critical care like treatment of cancer, infertility, obesity, diabetes & different renal problems. We have developed and scaled up around 25 Peptides

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • IN
  • 2020
    On CPHI since
  • 50 - 99
    Employees
Company types
Pharmaceutical company
View company profile
Contact info
  • +91 90995 05299
  • 333/334, GIDC Makarpura,, Makarpura GIDC, Vadodara, 390010, Gujarat, India
Show contact info Hide contact info
Event information
CPHI Frankfurt 2025
  • 28 Oct 2025 - 30 Oct 2025
  • Messe, Frankfurt
  • Visit us at stand 12.1F127, API

Products Featured at CPHI Frankfurt 2025

  • Complex Semi-synthetic APIs

    Product Complex Semi-synthetic APIs

    Micafungin Sodium, Anidulafungin-Fructose, Dalbavancin, Everolimus, Sarecycline, Midostaurin etc.
  • Omadacycline

    Product Omadacycline

    A tetracycline class antibacterial indicated for the treatment of adult patients with the following infections caused by susceptible microorganisms (1): Community-acquired bacterial pneumonia (CABP) (1.1); Acute bacterial skin and skin structure infections (ABSSSI) 
  • Semaglutide

    Product Semaglutide

    Indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus ,  to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction or non-fatal stroke) in adults with type 2 diabetes mellitus and est...
  • Rezafungin

    Product Rezafungin

    Rezafungin is a next-generation, semi-synthetic, cyclic lipopeptide and echinocandin derivative, with potential antifungal activity. 
  • Tirzepatide

    Product Tirzepatide

    Glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. 

  • Cetrorelix Acetate

    Product Cetrorelix Acetate

    Indicated for the inhibition of premature LH surges in women undergoing controlled ovarian stimulation.
  • Degarelix Acetate

    Product Degarelix Acetate

    Indicated for treatment of patients with advanced prostate cancer.
  • Apremilast

    Product Apremilast

    Indicated in Psoriatic Arthritis, Psoriasis and Oral Ulcers Associated with Behçet’s Disease
  • Bedaquiline Fumarate

    Product Bedaquiline Fumarate

    Diarylquinoline antimycobacterial drug indicated as part of combination therapy in the treatment of adult and pediatric patients (5 years and older and weighing at least 15 kg) with pulmonary multi-drug resistant tuberculosis (MDR-TB).
  • Binimetinib

    Product Binimetinib

    Indicated, in combination with encorafenib, for the treatment of patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation
  • Brivaracetam

    Product Brivaracetam

    Indicated for the treatment of partial-onset seizures in patients 4 years of age and older.
  • Carbetocin

    Product Carbetocin

    Used to prevent excessive bleeding after childbirth, particularly following Cesarean section.
  • Crisaborole

    Product Crisaborole

    Indicated for topical treatment of mild to moderate atopic dermatitis in adult and pediatric patients 3 months of age and older.
  • Deutetrabenazine

    Product Deutetrabenazine

    Indicated for the treatment of chorea associated with Huntington’s disease, tardive dyskinesia in adults.
  • Erdafitinib

    Product Erdafitinib

    Indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma (mUC), that has susceptible FGFR3 or FGFR2 genetic alterations, and progressed during or following at least one line of prior platinum-containing chemotherapy, including within 12 months of neoadjuva...
  • Etelcalcetide

    Product Etelcalcetide

    Iindicated for the treatment of secondary hyperparathyroidism (HPT) in adult patients with chronic kidney disease (CKD) on hemodialysis.
  • Everolimus

    Product Everolimus

    Indicated for Prophylaxis of Organ Rejection in Kidney Transplantation and Prophylaxis of Organ Rejection in Liver Transplantation
  • Fulvestrant

    Product Fulvestrant

    Indicated for the treatment of Hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer in postmenopausal women not previously treated with endocrine therapy, or HR-positive advanced breast cancer in postmenopausal women with disease progression...
  • Ganirelix Acetate

    Product Ganirelix Acetate

    Indicated for the inhibition of premature LH surges in women undergoing controlled ovarian hyperstimulation. Close
  • Ixazomib Citrate

    Product Ixazomib Citrate

    Indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy.
  • Lanreotide Acetate

    Product Lanreotide Acetate

    Indicated for the long-term treatment of acromegalic patients who have had an inadequate response to surgery and/or radiotherapy, or for whom surgery and/or radiotherapy is not an option.
  • Ribociclib Succinate

    Product Ribociclib Succinate

    Indicated in combination with an aromatase inhibitor for the treatment of pre/perimenopausal or postmenopausal women, with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer, as initial endocrine-based therapy; or fulvestrant ...
  • Leuprolide Acetate

    Product Leuprolide Acetate

    Indicated in the palliative treatment of advanced prostatic cancer.
  • Linaclotide

    Product Linaclotide

    Indicated in adults for the treatment of irritable bowel syndrome with constipation (IBS-C), chronic idiopathic constipation (CIC)
  • Liraglutide

    Product Liraglutide

    Indicated as an adjunct to diet and exercise to improve glycemic control in patients 10 years and older with type 2   diabetes mellitus,  to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial   infarction, or non-fat...
  • Mebendazole (Micronized)

    Product Mebendazole (Micronized)

    Indicated for the treatment of patients two years of age and older with gastrointestinal infections caused by Ancylostoma duodenale (hookworm), Ascaris lumbricoides (roundworm), Enterobius vermicularis (pinworm), Necator americanus (hookworm), and Trichuris trichiura (whipworm).
  • Midodrine Hydrochloride

    Product Midodrine Hydrochloride

    Indicated for the treatment of symptomatic orthostatic hypotension (OH).
  • Midostaurin

    Product Midostaurin

    Indicated, in combination with standard cytarabine and daunorubicin induction and cytarabine consolidation chemotherapy, for the treatment of adult patients with newly diagnosed acute myeloid leukemia (AML) who are FLT3 mutation-positive, as detected by a FDA approved test
  • Nintedanib Esylate

    Product Nintedanib Esylate

    Indicated for treatment of Idiopathic Pulmonary Fibrosis,  Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype, Systemic Sclerosis-Associated Interstitial Lung Disease
  • Nitisinone

    Product Nitisinone

    Indicated for the treatment of adult and pediatric patients with hereditary tyrosinemia type 1 (HT-1) in combination with dietary restriction of tyrosine and phenylalanine.
  • Obeticholic acid

    Product Obeticholic acid

    Indicated for the treatment of primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UDCA) in adults with an inadequate response to UDCA, or as monotherapy in adults unable to tolerate UDCA.
  • Octreotide Acetate

    Product Octreotide Acetate

    Indicated for treatment of Acromegaly, Carcinoid Tumors, VIP-secreting tumors.
  • Oxytocin Acetate

    Product Oxytocin Acetate

    For the temporary relief of symptoms of food cravings, including: constant appetite, increased or insatiable hunger. The peripheral actions of oxytocin mainly reflect secretion from the pituitary gland.
    Purity not les sthan 99% Complete impurity characterization available
  • Pentetreotide

    Product Pentetreotide

    Indium In-111 pentetreotide is an agent for the scintigraphic localization of primary and metastatic neuroendocrine tumors bearing somatostatin receptors.
  • Plecanatide

    Product Plecanatide

    Indicated in adults for the treatment of: chronic idiopathic constipation (CIC).  irritable bowel syndrome with constipation (IBS-C)
  • Rufinamide

    Product Rufinamide

    Indicated for adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome in pediatric patients 1 year of age and older and in adults.
  • Sarecycline Hydrochloride

    Product Sarecycline Hydrochloride

    Iindicated for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients 9 years of age and older.
  • Selexipag

    Product Selexipag

    Indicated for the treatment of pulmonary arterial hypertension (PAH, WHO Group I) to delay disease progression and reduce the risk of hospitalization for PAH.
  • Sincalide

    Product Sincalide

     Used as a diagnostic tool to stimulate gallbladder contraction, as may be assessed by various methods of diagnostic imaging, or to obtain by duodenal aspiration a sample of concentrated bile for analysis of cholesterol, bile salts, phospholipids, and crystals; to stimulate pancreatic secretio...
  • Sugammadex Sodium

    Product Sugammadex Sodium

    Indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adults undergoing surgery.
  • Terlipressin Acetate

    Product Terlipressin Acetate

    Analogue of vasopressin used as a vasoactive drug in the management of low blood pressure. It has been found to be effective when norepinephrine does not help.
  • Tofacitinib Citrate

    Product Tofacitinib Citrate

    Indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response or intolerance to methotrexate. It may be used as monotherapy or in combination with methotrexate or other nonbiologic disease-modifying antirheumatic drugs...
  • Triptorelin Acetate

    Product Triptorelin Acetate

    For the synchronization of time of insemination in weaned sows to facilitate a single fixed-time artificial insemination.
  • Vasopressin

    Product Vasopressin

    Indicated for patients with hemophilia A with factor VIII coagulant activity levels greater than 5%.
  • Vismodegib

    Product Vismodegib

    Indicated for the treatment of adults with metastatic basal cell carcinoma, or with locally advanced basal cell carcinoma that has recurred following surgery or who are not candidates for surgery and who are not candidates for radiation.